Tema ETFs’s SpringWorks Therapeutics SWTX Stock Holding History

Tema ETFs’s Portfolio SWTX Stock Details SWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-30,811	Closed	-$1.11M	–	168
2024 Q4	$1.11M	Buy	+30,811	New	+$1.08M	0.46%	60

Other funds holding SWTX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

PCH

Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Tema ETFs's SWTX Position: Q1 2025 in Review

Tema ETFs sold out of SpringWorks Therapeutics (SWTX) in Q1 2025, closing a stake of 30,811 shares — an estimated $1.11M sold.

Tema ETFs first reported a position in SWTX in Q4 2024 and held it in 1 quarter. The position peaked at $1.11M in Q4 2024. 306 funds tracked by Wall St. Rank hold SWTX as of Q1 2025.

Tema ETFs reported no remaining SpringWorks Therapeutics position as of Q1 2025 after selling out during the quarter.
Tema ETFs sold 30,811 SpringWorks Therapeutics shares in Q1 2025, an estimated $1.11M.
Tema ETFs first reported a position in SpringWorks Therapeutics in Q4 2024 and held it in 1 quarter.
Tema ETFs's SpringWorks Therapeutics position peaked at $1.11M in Q4 2024.
306 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q1 2025.

Based on Tema ETFs's 13F filing for Q1 2025, filed 14 May 2025.